Stereotaxis

$4.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (+2.25%) Today

$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Stereotaxis and other stocks, options, and ETFs commission-free!

About STXS

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Niobe System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO. The listed name for STXS is Stereotaxis, Inc. Common Stock.

CEO

David Leo Fischel

Employees

118

Headquarters

St. Louis, Missouri

Founded

1990

Market Cap

335.27M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

121.37K

High Today

$4.55

Low Today

$4.30

Open Price

$4.48

Volume

130.91K

52 Week High

$5.82

52 Week Low

$1.70

Collections

STXS Earnings

-$0.05

-$0.03

-$0.02

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 9, Pre-Market